Related Experiment Video
Updated: Jul 3, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Hormesis: implications for cancer risk assessment.
Jonathan Borak1, Greg Sirianni
1Departments of Medicine and Epidemiology and Public Health, Yale University, 234 Church Street #1100, New Haven, CT 06510, USA. jborak@jborak.com
Summary
Hormesis, a non-linear dose-response, is often insufficient to justify cancer risk assessment changes. Inconsistent findings across organs and species highlight the need for mechanistic studies rather than relying solely on hormesis.
Area of Science:
- Toxicology
- Carcinogenesis
- Risk Assessment
Background:
- Current cancer risk assessment guidelines prioritize "mode of action" over dose-response data for linear low-dose extrapolation.
- Demonstrating hormesis is typically not enough to justify a non-linear approach in policy decisions, despite its insights into toxicant actions.
Purpose of the Study:
- To evaluate the dose-response characteristics of four carcinogens with reported hormetic effects.
- To determine if hormesis alone is sufficient to justify non-linear low-dose extrapolations in cancer risk assessment.
Main Methods:
- Reviewed studies on cadmium chloride, ionizing radiation, polycyclic aromatic hydrocarbons (PAHs), and 2,3,7,8-TCDD reporting hormesis.
- Analyzed dose-response data across different organs, species, and related carcinogens within the reviewed studies.
Main Results:
- Inconsistent dose-response patterns were observed: hormesis in one organ often coexisted with non-hormetic responses in others or with similar carcinogens.
- Data were insufficient to determine if hormesis is a property of the toxicant, target organ, or species.
Conclusions:
- Hormesis alone is insufficient to justify non-linear low-dose extrapolations for cancer risk assessment due to observed inconsistencies.
- The primary value of hormesis in risk assessment lies in its potential to stimulate mechanistic studies to understand toxicant actions.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...